BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Business

  Aldeyra Therapeutics Schedules Webcast and Conference Call to Report Third-Quarter 2022 Financial Results and Discuss Recent Corporate Highlights

  Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call at 8:00 a.m. ET Thursday, November 10, 2022 to report financial results for the quarter ended September 30, 2022 and discuss recent corporate highlights.

  November 3, 2022

   · 

  1 min read
• Business

  Geron Corporation Reports Third Quarter 2022 Financial Results and Upcoming Expected Milestones

  Geron Corporation today reported financial results for the third quarter of 2022 and upcoming expected milestones.

  November 3, 2022

   · 

  19 min read
• BioCapital

  ATCC Announces New Immuno-oncology CAR-T Target Luciferase Reporter Cell Lines to Enable Discovery and Development of Immunotherapies

  ATCC today announced a new line of products, CAR-T Target luciferase reporter cell lines, that will support immuno-oncology (IO) discovery and development of novel immunotherapies.

  November 3, 2022

   · 

  3 min read
• Genetown

  ElevateBio BaseCamp Unveils its LentiPeakTM Lentiviral Vector Platform

  ElevateBio, LLC (ElevateBio), a technology-driven company focused on powering transformative cell and gene therapies, today announced the unveiling of ElevateBio BaseCamp’s proprietary LentiPeakTM lentiviral vector platform.

  November 3, 2022

   · 

  4 min read
• Biotech Bay

  OrsoBio Announces Presentation of Five Abstracts at AASLD’s The Liver Meeting® 2022 Highlighting Programs for Severe Metabolic Disorders

  OrsoBio Announces Presentation of Five Abstracts at AASLD’s The Liver Meeting ® 2022 Highlighting Programs for Severe Metabolic Disorders.

  November 3, 2022

   · 

  6 min read
• Genetown

  Vertex to Present New Data on its Portfolio of Cystic Fibrosis Medicines at the 2022 North American Cystic Fibrosis Conference

  Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that multiple abstracts on the company’s portfolio of cystic fibrosis (CF) medicines will be presented in posters and oral presentations at this year’s North American Cystic Fibrosis Conference.

  November 3, 2022

   · 

  11 min read
• BioCapital

  Thermo Fisher Scientific and Society for Science Launch Junior Innovators Challenge to Inspire More Than 65,000 Future STEM Leaders Nationwide

  Thermo Fisher Scientific Inc., the world leader in serving science, and Society for Science, announced the Thermo Fisher Scientific Junior Innovators Challenge, the nation’s premier middle school science, technology, engineering and math competition.

  November 3, 2022

   · 

  5 min read
• Business

  UroGen Pharma to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022

  UroGen Pharma Ltd. today announced that it will report third quarter 2022 financial results on Thursday, November 10, 2022, prior to the open of the market.

  November 3, 2022

   · 

  1 min read
• Business

  Edgewise Therapeutics Reports Third Quarter 2022 Financial Results

  Edgewise Therapeutics, Inc. today reported financial results for the third quarter of 2022 and recent business highlights.

  November 3, 2022

   · 

  12 min read